Source-grounded facts extracted from CEMTREX INC's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
CEMTREX INC: Filed Certificate of Amendment to effect a 1-for-10 reverse stock split of common stock (effective 2026-06-05).
“On June 2, 2026, the Company filed a Certificate of Amendment to its Certificate of Incorporation (the “Charter Amendment”) with the Secretary of State of the State of Delaware, pursuant to which, effective at 12:01 a.m. Eastern Time on June 5, 2026, the Reverse Split will be effected.”
CEMTREX INC shareholders approved Ratification of Grassi Co. Certified Public Accountants as independent registered public accounting firm at the 2026-05-15 meeting.
“Proposal 2 - Ratification of the Appointment of the Company’s Independent registered public accounting firm”
CEMTREX INC shareholders approved Election of four nominees to the Board of Directors at the 2026-05-15 meeting.
“Number of Votes Nominee For Abstain Broker Non-Votes Saagar Govil 102,741,275 495,703 4,399,719 Brian Kwon 102,988,319 248,658 4,399,720 Manpreet Singh 102,954,394 282,583 4,399,720 Mitodi Filipov 102,987,501 249,476 4,399,720”
CEMTREX INC entered into Share Purchase Agreement with Karl F. Kiefer valued at $7,060,000 (effective 2025-11-13).
“Cemtrex, Inc. (the “Company”) entered into a Share Purchase Agreement (the “Agreement”) with Karl F. Kiefer, an individual resident of Texas (the “Seller”), and Invocon, Inc., a Texas corporation (“Invocon”), pursuant to which the Company agreed to acquire 100% of the issued and outstanding shares of Invocon for a purchase price of $7,060,000 in cash.”
CEMTREX INC completed an acquisition involving Invocon Inc. for $7,060,000 (closed 2026-01-08).
“The purchase price of $7,060,000 was paid in cash at closing.”
CEMTREX INC completed an acquisition involving Richland Industries LLC for purchased the business assets and property for $5.5 million (closed 2026-02-05).
“and current backlog, AIS Tennessee is expected to contribute approximately $8 to $10M in revenue over the next twelve months. AIS purchased the business assets and property for $5.5 million and assumed certain operating liabilities in connection with the transaction. The acquisition and property purchase was financed through loans from Fulton Bank, and no equity was”
CEMTREX INC entered into Securities Purchase Agreement with a single accredited institutional investor valued at aggregate gross proceeds of $4,000,000 (effective 2026-01-09).
“On January 9, 2026, Cemtrex, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a single accredited institutional investor (the “Purchaser”), pursuant to which the Company agreed to issue and sell to the Purchaser, in a registered direct offering (the “Offering”), securities consisting of shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and/or pre-funded warrants to purchase shares of Common Stock (the “Pre-Funded Warrants”), for aggregate gross proceeds of $4,000,000.”
CEMTREX INC completed an acquisition involving Karl F. Kiefer and Invocon, Inc. for $7,060,000 in cash (closed 2026-01-08).
“Invocon, Inc., a Texas corporation (“Invocon”), pursuant to which the Company agreed to acquire 100% of the issued and outstanding shares of Invocon for a purchase price of $7,060,000 in cash. On January 8, 2026, the Company completed the acquisition of Invocon. As a result of the transaction, Invocon became a wholly-owned subsidiary of the Company. The”
CEMTREX INC entered into Securities Purchase Agreement with a single accredited institutional investor valued at aggregate gross proceeds of $2,000,000 (effective 2025-12-30).
“On December 30, 2025, Cemtrex, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a single accredited institutional investor (the “Purchaser”), pursuant to which the Company agreed to issue and sell to the Purchaser, in a registered direct offering (the “Offering”), securities consisting of shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and/or pre-funded warrants to purchase shares of Common Stock (the “Pre-Funded Warrants”), for aggregate gross proceeds of $2,000,000.”
CEMTREX INC entered into Securities Purchase Agreement with a single accredited institutional investor valued at aggregate gross proceeds of $2,000,000 (effective 2025-12-23).
“On December 23, 2025, Cemtrex, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a single accredited institutional investor (the “Purchaser”), pursuant to which the Company agreed to issue and sell to the Purchaser, in a registered direct offering (the “Offering”), securities consisting of shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and/or pre-funded warrants to purchase shares of Common Stock (the “Pre-Funded Warrants”), for aggregate gross proceeds of $2,000,000.”
CEMTREX INC entered into Securities Purchase Agreement valued at $2,000,000 (effective 2025-12-11).
“On December 11, 2025, Cemtrex, Inc. (the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with a single accredited institutional investor (the “Purchaser”), pursuant to which the Company agreed to issue and sell to the Purchaser, in a registered direct offering (the “Offering”), securities consisting of shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), and/or pre-funded warrants to purchase shares of Common Stock (the “Pre-Funded Warrants”), for aggregate gross proceeds of $2,000,000.”
CEMTREX INC issued 2,234,247 Series B Warrants of warrant for $5.5 million proceeds.
“2,234,247 shares of common shares upon the exercise of 2,234,247 Series B Warrants. The Company received $5.5 million proceeds on the exercises of the Series B Warrants.”
CEMTREX INC issued 9,981 Series A Warrants of warrant.
“The Company also issued 29,943 shares of common stock upon the exercise of 9,981 Series A Warrants”
CEMTREX INC issued 2,500,609 shares of common stock to certain lenders for $6,084,000 of debt.
“On December 8, 2025, the company issued 2,500,609 shares of its common stock pursuant to exchange agreement to satisfy $6,084,000 of debt with certain lenders.”
CEMTREX INC: Certificate of Amendment filed to effect a 1-for-15 reverse stock split (effective 2025-09-29).
“On September 24, 2025, the Company filed a Certificate of Amendment to its Certificate of Incorporation (the “Charter Amendment”) with the Secretary of State of the State of Delaware, pursuant to which, effective at 12:01 a.m. Eastern Time on September 29, 2025, the Reverse Split will be effected.”
CEMTREX INC issued preferred stock to holders of record of Series 1 Preferred Stock for 10% annual dividend on $10.00 per share Preference Amount.
“October 7, 2025, to the holders of record on close of business on September 30, 2025. The holders of the Series 1 Preferred Stock are entitled to receive dividends at the rate of 10% annually, based on the $10.00 per share Preference Amount, payable semiannually. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant”
CEMTREX INC received a nasdaq compliance regained notice regarding stockholders equity (rules 5550(b)(1)).
“June 4, 2025, the Company received a letter from Nasdaq notifying the Company that based on the Company’s Form 10-Q for the period ended March 31, 2025, filed on May 15, 2025, evidencing stockholders’ equity of $6,403,022, Nasdaq has determined that the Company complies with the Minimum Stockholder’s Equity Requirement and this matter is now closed.”
CEMTREX INC received a nasdaq compliance regained notice regarding late filing (rules 5550(b)(1)).
“August 20, 2025, the Company must complete the submitted plan and opt for one of the two following alternatives to evidence compliance with the Rule: Alternative 1 : The Company must furnish to the SEC and Nasdaq a publicly available report (e.g., a Form 8-K) including: 1. A disclosure of Staff’s deficiency letter and the specific deficiency(ies) cited; 2. A description of the completed transaction or event that enabled the Company to satisfy the stockholders’ equity requirement for continued listing; 3. An affirmative statement that, as of the date of the report, the Company believes it h”
CEMTREX INC received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).
“February 21, 2025, Cemtrex, Inc. (the “Company”) received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because the stockholder’s equity for the Company was below $2,500,000 as reported on our Form 10-Q for the period ended December 31, 2024, the Company no longer meets the minimum shareholder’s equity requirement for continued listing on The Nasdaq Capital Market under Nasdaq Marketplace Rule 5550(b)(1), requiring a minimum stockholder’s equity of $2,500,000 (the “Minimum Stockholder’s Equity Requirement””
CEMTREX INC received a nasdaq noncompliance notice notice regarding stockholders equity (rules 5550(b)(1)).
“January 2, 2025, the Company received a letter from Nasdaq notifying the Company that based on the Company’s Form 10-K filed on December 30, 2024, evidencing stockholders’ equity of $4,710,677, Nasdaq has determined that the Company complies with the Minimum Stockholder’s Equity Requirement and this matter is now closed.”
Paul J. Wyckoff was appointed as Chief Financial Officer at CEMTREX INC.
“On January 6, 2025, Paul J. Wyckoff was appointed Cemtrex’s Chief Financial Officer”
CEMTREX INC received a nasdaq compliance regained notice regarding stockholders equity (rules 5550(b)(1)).
“January 2, 2025, the Company received a letter from Nasdaq notifying the Company that based on the Company’s Form 10-K filed on December 30, 2024, evidencing stockholders’ equity of $4,710,677, Nasdaq has determined that”
CEMTREX INC: 1-for-35 reverse stock split approved; Certificate of Amendment filed with Delaware Secretary of State (effective 2024-11-26).
“On November 21, 2024, the Company filed a Certificate of Amendment to its Certificate of Incorporation (the “Charter Amendment”) with the Secretary of State of the State of Delaware, pursuant to which, effective at 12:01 a.m. Eastern Time on November 26, 2024, the Reverse Split will be effected.”
CEMTREX INC shareholders approved Ratification of Grassi Co. Certified Public Accountants as independent registered public accounting firm for fiscal year ending September 30, 2024 at the 2024-05-16 meeting.
“Proposal 2 - Ratification of the Appointment of the Company’s Independent registered public accounting firm: Voting to ratify Grassi Co. Certified Public Accountants as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2024: ● For: 13,941,365 ● Against: 36,602 ● Abstain; 38,860”
CEMTREX INC shareholders approved Election of four nominees to the Board of Directors at the 2024-05-16 meeting.
“Proposal 1 – Voting to elect four nominees to the Company’s Board of Directors (the “Board”) for a one-year term expiring at the next Annual Meeting of Shareholders, or until their successors are elected and qualified: Number of Votes Nominee For Abstain Broker Non-Votes Saagar Govil 12,247,618 519,657 1,249,552”
CEMTREX INC entered into Underwriting Agreement with Aegis Capital Corp. valued at aggregate gross proceeds to the Company were approximately $10,035,000 (effective 2024-05-01).
“On May 1, 2024, Cemtrex, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Aegis Capital Corp. (the “Underwriter”), in connection with a firm commitment underwritten public offering”
CEMTREX INC entered into Standstill Agreement with Streeterville Capital, LLC valued at the greater of $4 million or fifty percent (50%) of the net proceeds (effective 2024-04-30).
“On April 30, 2024, Cemtrex, Inc., a Delaware corporation (the “Company”) entered into a Standstill Agreement (the “Agreement”) with Streeterville Capital, LLC (“Streeterville”).”
CEMTREX INC received a nasdaq delisting notice notice regarding other.
“January 18, 2024, the Company received a letter from The Nasdaq Stock Market LLC’s Hearings Panel notifying the Company that it has determined to delist Cemtrex Inc.’s (the “Company”) shares of Series 1 Preferred Stock from the Exchange, due to the Company’s inability to meet the terms of the exception granted by the Panel on September 8, 2023, as amended. Suspension of trading in the Company’s Series 1 Preferred Stock will be effective at the open of business on January 22, 2024.”
CEMTREX INC received a nasdaq hearing update notice regarding minimum bid price (rules 5555(a)(1)).
“January 3, 2024, the Company received a letter from The Nasdaq Stock Market LLC’s Hearings Panel notifying the Company that it has made the following amendments to the exception granted on September 8, 2023. ● On January 8, 2024, the Company’s Series 1 Preferred Stock shall close at a minimum bid price of at least $1 per share and maintain such closing bid price for a minimum of ten consecutive business days; ● 2. On January 22, 2024, the Company shall have demonstrated compliance with Listing Rule 5555(a)(1), by evidencing a closing bid price of $1 or more per share for a minimum of ten c”
CEMTREX INC entered into Asset Purchase Agreement with Heisey Mechanical, Ltd. (effective 2023-07-01).
“the Acquisition was effected pursuant to the Asset Purchase Agreement, dated as of June 7, 2023, by and among the Company, Buyer, and the Sellers, (the “Asset Purchase Agreement”).”
CEMTREX INC received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5555(a)(1)).
“January 5, 2024, and described the actions it intends to take to be able to meet that timeline. Accordingly, the Company has been granted an exception until January 19, 2024, to effect the reverse stock split and thereafter regain compliance with the Bid Price Rule.”
CEMTREX INC received a nasdaq delisting notice notice regarding minimum bid price.
“July 25, 2023, the Company received a Notice of Staff Determination from the Listing Qualifications Department of Nasdaq notifying the Company that its Series 1 Preferred Stock had not gained compliance and would be suspended from trading at the opening of business on August 3, 2023. The Company has requested a hearing regarding the delisting which will stay the suspension and filing of Form 25-NSE with the Securities and Exchange Commission (the “SEC”). On July 25, 2023, the Company received notification that it had been granted a hearing on September 14, 2023. The Company intends to continue”
CEMTREX INC received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).
“July 25, 2023, the Company received a Notice of Staff Determination from the Listing Qualifications Department of Nasdaq notifying the Company that its Series 1 Preferred Stock had not gained compliance and would be suspended from trading at the opening of business on August 3, 2023. The Company has requested a hearing regarding the delisting which will stay the suspension and filing of Form 25-NSE with the Securities and Exchange Commission (the “SEC”). The Company intends to continue actively monitoring the bid price for its Series 1 preferred stock between now and the hearing date and will”
CEMTREX INC received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).
“July 29, 2022, Cemtrex, Inc. (the “Company”) received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because the closing bid price for the Company’s Series 1 preferred stock listed on Nasdaq was below $1.00 for 30 consecutive trading days, the Company no longer met the minimum bid price requirement for continued listing on The Nasdaq Capital Market under Nasdaq Marketplace Rule 5550(a)(2), requiring a minimum bid price of $1.00 per share (the “Minimum Bid Price Requirement”). On January 26, 2023, the Compan”
CEMTREX INC shareholders approved Ratification of the Appointment of the Company’s Independent registered public accounting firm: Voting to ratify Grassi Co. Certified Public Accountants as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2023: at the 2023-05-26 meeting.
“Proposal 2 - Ratification of the Appointment of the Company’s Independent registered public accounting firm: Voting to ratify Grassi Co. Certified Public Accountants as the Company’s independent registered public accounting firm for the fiscal year ending September 30, 2023: ● For: 10,720,103 ● Against: 500,110 ● Abstain; 172,943 Proposal 2 was approved by the Company’s shareholders, consistent with the recommendation from the Board.”
CEMTREX INC shareholders approved Voting to elect four nominees to the Company’s Board of Directors (the “Board”) for a one-year term expiring at the next Annual Meeting of Shareholders, or until their successors are elected and qualified: at the 2023-05-26 meeting.
“Proposal 1 – Voting to elect four nominees to the Company’s Board of Directors (the “Board”) for a one-year term expiring at the next Annual Meeting of Shareholders, or until their successors are elected and qualified: Number of Votes Nominee For Abstain Broker Non-Votes Saagar Govil 9,224,808 585,869 1,582,763 Brian Kwon 9,422,257 388,320 1,582,863 Manpreet Singh 9,417,269 393,308 1,582,863 Mitodi Filipov 9,417,269 393,308 1,582,863 Each nominee was elected by the Company’s shareholders, consistent with the recommendation from the Board.”
CEMTREX INC received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).
“February 8, 2023, the Company received a notification letter from the Listing Qualifications Department of Nasdaq notifying the Company that it has regained compliance with Listing Rule 5550(a)(2) and is in compliance with all applicable listing standards. The Company’s common stock will continue to be listed and traded on The Nasdaq Stock Market. The hearing scheduled for March 16, 2023 before the Hearings Panel has be cancelled.”
CEMTREX INC received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).
“daq notifying the Company that, because the closing bid price for the Company’s common stock listed on Nasdaq was below $1.00 for 30 consecutive trading days, the Company no longer met the minimum bid price requirement for continued listing on The Nasdaq Capital Market under Nasdaq Marketplace Rule 5550(a)(2), requiring a minimum bid price of $1.00 per share (the “Minimum Bid Price Requirement”). On July 26, 2022, the Company received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC Nasdaq notifying the Company that, it had been granted an additio”
CEMTREX INC: Effected a one-for-thirty-five reverse stock split via Certificate of Amendment to the Certificate of Incorporation (effective 2023-01-23).
“Effective as of January 23, 2023, Cemtrex, Inc. (the “Company”) will effect a reverse stock split of its outstanding shares of common stock at a ratio of one-for-thirty five (the “Reverse Split”).”
CEMTREX INC completed a disposition involving Saagar Govil for $895,000 comprised of: $75,000 in cash payable at Closing; and 5% royalty...; and $10,000 in cash payable at Closing; 5% royalty...; and $1,600,000 in SAFE (closed 2022-11-22).
“development services for startups to large enterprises. On November 22, 2022, the Company completed the above disposition for the following consideration; ● Cemtrex XR, Inc. ○ $895,000 comprised of: ■ $75,000 in cash payable at Closing; and ■ 5% royalty of all revenues on the Business to be paid 90 days after the end of each calendar year for the next three”
CEMTREX INC entered into Simple Agreement for Future Equity with Saagar Govil valued at $1,600,000 in common equity upon fundraising or exit above $5M with a $10M cap (effective 2022-11-22).
“On November 22, 2022, Cemtrex, Inc. (the “Company”) entered into two Asset Purchase Agreements and one Simple Agreement for Future Equity (“SAFE”) with the Company’s CEO, Saagar Govil, to secure the sale of the following brands under the subsidiaries Cemtrex Advanced Technologies, Inc, and Cemtrex XR, Inc. to Mr. Govil, which were consolidated into the Company’s Condensed Consolidated Balance Sheet as of June 30, 2022, as filed with the SEC on August 15, 2022. - SmartDesk – SmartDesk is focused on reinventing the workspace through developing state-of-the-art, modern, fully integrated, workplace solutions. - Cemtrex XR (“CXR”) – CXR is focused on realizing the potential of the metaverse. CXR delivers Virtual Reality (VR) and Augmented Reality (AR) solutions that provide higher productivity, progressive design and impactful experiences for consumer products, and various commercial and industrial applications. The Company is in the process of developing virtual reality applications for co”
CEMTREX INC entered into Asset Purchase Agreement for Cemtrex Advanced Technologies, Inc. with Saagar Govil valued at $10,000 cash, 5% royalty on revenues for five years, and $1,600,000 in SAFE (effective 2022-11-22).
“On November 22, 2022, Cemtrex, Inc. (the “Company”) entered into two Asset Purchase Agreements and one Simple Agreement for Future Equity (“SAFE”) with the Company’s CEO, Saagar Govil, to secure the sale of the following brands under the subsidiaries Cemtrex Advanced Technologies, Inc, and Cemtrex XR, Inc. to Mr. Govil, which were consolidated into the Company’s Condensed Consolidated Balance Sheet as of June 30, 2022, as filed with the SEC on August 15, 2022. - SmartDesk – SmartDesk is focused on reinventing the workspace through developing state-of-the-art, modern, fully integrated, workplace solutions. - Cemtrex XR (“CXR”) – CXR is focused on realizing the potential of the metaverse. CXR delivers Virtual Reality (VR) and Augmented Reality (AR) solutions that provide higher productivity, progressive design and impactful experiences for consumer products, and various commercial and industrial applications. The Company is in the process of developing virtual reality applications for co”
CEMTREX INC entered into Asset Purchase Agreement for Cemtrex XR, Inc. with Saagar Govil valued at $75,000 cash and 5% royalty on revenues for three years, with minimum aggregate of $820,000 (effective 2022-11-22).
“On November 22, 2022, Cemtrex, Inc. (the “Company”) entered into two Asset Purchase Agreements and one Simple Agreement for Future Equity (“SAFE”) with the Company’s CEO, Saagar Govil, to secure the sale of the following brands under the subsidiaries Cemtrex Advanced Technologies, Inc, and Cemtrex XR, Inc. to Mr. Govil, which were consolidated into the Company’s Condensed Consolidated Balance Sheet as of June 30, 2022, as filed with the SEC on August 15, 2022. - SmartDesk – SmartDesk is focused on reinventing the workspace through developing state-of-the-art, modern, fully integrated, workplace solutions. - Cemtrex XR (“CXR”) – CXR is focused on realizing the potential of the metaverse. CXR delivers Virtual Reality (VR) and Augmented Reality (AR) solutions that provide higher productivity, progressive design and impactful experiences for consumer products, and various commercial and industrial applications. The Company is in the process of developing virtual reality applications for co”
Chris Wagner resigned as Board Member at CEMTREX INC.
“On November 8, 2022, Chris Wagner resigned his role as a Board Member for personal reasons.”
Paul J. Wyckoff was appointed as Interim Chief Financial Officer at CEMTREX INC.
“On January 28, 2022, Paul J. Wyckoff was appointed Cemtrex’s Interim Chief Financial Officer where he is responsible for the Company’s financial planning, accounting, tax, and business process functions.”
Christopher C. Moore departed as Chief Financial Officer at CEMTREX INC.
“On January 28, 2022, Christopher C. Moore was dismissed from his position as Chief Financial Officer ("CFO") at Cemtrex.”
Chris Wagner was appointed as Independent Director at CEMTREX INC.
“has appointed a new independent director. Chris Wagner, effective November 3, 2021.”
Manpreet Singh was appointed as Director and Audit Committee Member at CEMTREX INC.
“the “Company”) has appointed a new independent director and audit committee member, Manpreet Singh, CFA, effective November 1, 2021.”
Brian Kwon was appointed as independent director and audit committee member at CEMTREX INC.
“Cemtrex, Inc. (the “Company”) has appointed a new independent director and audit committee member, Brian Kwon, effective September 28, 2021.”
Sunil Verma resigned as Board Member at CEMTREX INC.
“On August 24, 2021, Sunil Verma resigned his role as a Board Member for personal reasons.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.